These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26104919)

  • 1. Impact of vibration and agitation speed on dissolution of USP prednisone tablets RS and various IR tablet formulations.
    Seeger N; Lange S; Klein S
    AAPS PharmSciTech; 2015 Aug; 16(4):759-66. PubMed ID: 26104919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
    Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
    Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vibration effects of lab equipment on dissolution testing with USP paddle method.
    Gao Z; Thies A; Doub W
    J Pharm Sci; 2010 Jan; 99(1):403-12. PubMed ID: 19544371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms.
    Wang Y; Armenante PM
    J Pharm Sci; 2012 Feb; 101(2):746-60. PubMed ID: 22083630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vibration effects on dissolution tests with USP apparatuses 1 and 2.
    Gao Z; Moore TW; Doub WH
    J Pharm Sci; 2008 Aug; 97(8):3335-43. PubMed ID: 18000813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.
    Zhang Y; Bredael G; Armenante PM
    J Pharm Sci; 2013 Aug; 102(8):2718-29. PubMed ID: 23861178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cause of high variability in drug dissolution testing and its impact on setting tolerances.
    Qureshi SA; Shabnam J
    Eur J Pharm Sci; 2001 Jan; 12(3):271-6. PubMed ID: 11113646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The random vibration effects on dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Buhse LF; Doub WH
    J Pharm Sci; 2009 Jan; 98(1):297-306. PubMed ID: 18399543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical modeling of variables involved in dissolution testing.
    Gao Z
    J Pharm Sci; 2011 Nov; 100(11):4934-42. PubMed ID: 21702052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of variability in dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Smith AP; Doub WH; Westenberger BJ
    J Pharm Sci; 2007 Jul; 96(7):1794-801. PubMed ID: 17252609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution.
    Röst M; Quist PO
    J Pharm Biomed Anal; 2003 Apr; 31(6):1129-43. PubMed ID: 12667929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of Discriminating and Biorelevant Dissolution Test for Lornoxicam Tablets.
    Anumolu PD; Sunitha G; Bindu SH; Satheshbabu PR; Subrahmanyam CV
    Indian J Pharm Sci; 2015; 77(3):312-20. PubMed ID: 26180277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Approach for the Application of USP Apparatus 3 in Dissolution Tests: Case Studies of Three Antihypertensive Immediate-Release Tablets.
    Espíndola B; Bortolon FF; Pinto JMO; Pezzini BR; Stulzer HK
    AAPS PharmSciTech; 2018 Oct; 19(7):2866-2874. PubMed ID: 29934804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a dissolution test method for vitamin A in dietary supplement tablets.
    Davydova N; Stippler E; Jin P; Giancaspro G
    J Pharm Biomed Anal; 2010 Nov; 53(3):295-301. PubMed ID: 20427140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method.
    Qiu Y; Garren J; Samara E; Cao G; Abraham C; Cheskin HS; Engh KR
    J Pharm Sci; 2003 Nov; 92(11):2317-25. PubMed ID: 14603516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminatory dissolution method for quality control measurements of carbamazepine immediate release tablets based on in vitro--in vivo investigations.
    Xu C; Zou M; Wang Y; Liu Y; Yan J; Wu Y; Cheng G
    Drug Dev Ind Pharm; 2012 Jun; 38(6):679-88. PubMed ID: 21988132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing.
    Bai G; Armenante PM
    J Pharm Sci; 2009 Apr; 98(4):1511-31. PubMed ID: 18781589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.